TrialClinical pharmacokinetics2022

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties.

Junichiro James Kazama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.